Application 125547
- Type
- BLA
- Sponsor
- ELI LILLY CO
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 125547 | Portrazza | necitumumab | 351(a) | Rx | 2026-06-01 |
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PORTRAZZA | NECITUMUMAB | INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL | 800MG/50ML | Yes | No |
NDC Listings For This Application#
NDC listings for this application page 1 of 1 ยท 1 matching rows.
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0002-7716 | Portrazza | necitumumab | Eli Lilly and Company | BLA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 44817 | ORIG | 2015-12-30 |
| 43337 | ORIG | 2015-12-30 |
| 39989 | ORIG | 2015-11-24 |
| 9781 | ORIG | 2015-11-24 |